TargetMol

S-312-d

Product Code:
 
TAR-T28646
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28646-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28646-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28646-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
S-312d is a calcium channel antagonist. S-312-d can offer marked neuronal protective effects against ischemic injury.
CAS:
120056-57-7
Formula:
C20H22N2O4S
Molecular Weight:
386.47
Purity:
0.98
SMILES:
COC(=O)C1=C(C)Nc2scc(CC(C)C)c2[C@H]1c1cccc(c1)[N+]([O-])=O

References

1. Keuroghlian AS, Gunderson JG, Pagano ME, Markowitz JC, Ansell EB, Shea MT, Morey LC, Sanislow C, Grilo CM, Stout RL, Zanarini MC, McGlashan TH, Skodol AE. Interactions of borderline personality disorder and anxiety disorders over 10 years. J Clin Psychiatry. 2015 Nov;76(11):1529-34. doi: 10.4088/JCP.14m09748. PubMed PMID: 26114336. 2. Patel NC, Palmer WC, Gill KR, Cangemi D, Diehl N, Stark ME. Changes in efficiency and resource utilization after increasing experience with double balloon enteroscopy. World J Gastrointest Endosc. 2013 Mar 16;5(3):89-94. doi: 10.4253/wjge.v5.i3.89. PubMed PMID: 23515876; PubMed Central PMCID: PMC3600554. 3. Whitney DW. Guide to preemption of state-law claims against Class III PMA medical devices. Food Drug Law J. 2010;65(1):113-39, ii-iii. PubMed PMID: 24475536. 4. Amano T, Aihua Z, Matsubayashi H, Seki T, Serikawa T, Sasa M, Sakai N. Antiepileptic effects of single and repeated oral administrations of S-312-d, a novel calcium channel antagonist, on tonic convulsions in spontaneously epileptic rats. J Pharmacol Sci. 2004 Jul;95(3):355-62. PubMed PMID: 15272212.